Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.910
-0.010 (-0.34%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Can-Fite BioPharma Stock Forecast
CANF's stock price has decreased by -87.12% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Can-Fite BioPharma stock has a target of 50, which predicts an increase of 1,618.21% from the current stock price of 2.91.
Analyst Consensus: Buy
* Price targets were last updated on Nov 4, 2025.
Analyst Ratings
The average analyst rating for Can-Fite BioPharma stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 24, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $220 → $80 | Strong Buy | Maintains | $220 → $80 | +2,649.14% | Dec 17, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $220 | Strong Buy | Maintains | $220 | +7,460.14% | Nov 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +1,618.21% | Nov 4, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $220 | Strong Buy | Maintains | $220 | +7,460.14% | Sep 16, 2025 |
Financial Forecast
Revenue This Year
11.00B
from 405.00K
Increased by 2,715,455.56%
Revenue Next Year
22.11B
from 11.00B
Increased by 101.06%
EPS This Year
n/a
from -5.97
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.3B | 45.5B | |
| Avg | 11.0B | 22.1B | |
| Low | 10.6B | 9.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2,795,208.6% | 313.9% | |
| Avg | 2,715,455.6% | 101.1% | |
| Low | 2,608,788.9% | -99.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.